Physical InactivityNCT07340580
Implementation Facilitation of Exercise is Medicine Greenville
A study testing Clinic Implementation Facilitation in people with Physical Inactivity and Dyslipidemia, run by University of South Carolina at 1 site in United States.
Trial summary
A public health priority exists for the U.S. healthcare sector to integrate physical activity (PA) as a part of the patient care model. This research will provide valuable information on facilitating optimal implementation of a clinic-to-community model that identifies, refers, and enrolls physically inactive patients… Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Physical Inactivity, Dyslipidemia, Obesity and Overweight
- What is being tested?
- Clinic Implementation Facilitation
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 35 participants
- Where
- 1 siteUnited States
- Study dates
- 1 May 2026to 31 Jul 2030
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Received an EIMG referral and scheduled for orientation
- Attending orientation at two pre-determined community PA facilities (these sites were selected due to each being the largest urban and rural YMCA referral sites in the study)
- Received an EIMG referral
Who cannot join
- Not EIMG-activated
- Adopted EIMG < 6 months prior to the beginning of this study
- Greater than 15 miles from the nearest YMCA
- 1. Primary care clinic staff (primary aim) Inclusion criteria
- At least 18 years of age
- Has worked at the Prisma Health-Upstate clinic since the start date of the intervention in the respective wave, i.e., Pre-IF start date for each wave
Show all 73Show fewer
- Has clinical encounters with a minimum of 25 patients per month
- Study clinic is their primary clinic (>50% of their working time)
- Able to understand and communicate in English
- Less than 18 years of age
- Work at the Prisma Health-Upstate clinic started after the Pre-IF phase began
- Has clinical encounters with <25 patients per month
- Unable to speak or understand English
- Adults unable to provide consent
- 2. Patient (secondary aim) Inclusion criteria (must meet all of below)
- Age >= 18 and <= 80 years
- Clinically eligible (diagnosis of hypertension, dyslipidemia, obesity, diabetes, or physical inactivity) to receive an EIMG referral
- A healthcare visit with an eligible encounter type (evaluation, telemedicine, consult, office visit, e-visit, follow-up, appointment, education, multidisciplinary visit, nutrition, occupational medicine-office visit)
- A healthcare visit at a participating clinic
- Age < 18 or > 80 years
- Current referral to Physical therapy or occupational therapy
- Current referral to cardiac, pulmonary, or oncology rehab
- One of the following visit diagnoses listed below:
- Alzheimer's disease
- Amyotrophic lateral sclerosis
- angina or chest pain
- congenital stenosis of aortic valve
- congenital insufficiency of aortic valve
- moderate or severe persistent asthma
- typical or atypical atrial flutter
- autonomic dysreflexia
- acute bronchitis
- cerebral infarction
- encounter for chemotherapy
- chronic kidney disease (stage 3-5)
- end stage renal disease
- coma
- acute chronic obstructive pulmonary disease
- unspecified dementia
- dependence on renal dialysis
- trisomy 21
- pulmonary embolism
- venous embolism and thrombosis
- history of falling
- acute fracture
- left ventricular failure
- congestive heart failure
- hypertensive urgency, emergency or crisis
- diabetes with ketoacidosis
- chronic respiratory failure
- dependence on supplemental oxygen
- myocardial infarction
- osteoporosis with current fracture
- encounter for palliative care
- paraplegia or quadriplegia
- Parkinson disease
- pneumonia
- encounter for supervision of pregnancy
- encounter for radiation therapy
- serious mental illness (schizophrenia, psychotic disorder)
- homicidal or suicidal ideations
- sepsis
- injury of spinal cord
- presence of coronary stent
- dependence on wheelchair or ambulatory aid
- For patients completing accelerometry data collection, the additional inclusion/exclusion criteria apply:
- Unable to provide verbal informed consent
- Planning on travel or vacation during data collection, as patient PA behavior is anticipated to differ from 'everyday' PA behavior at home
- Unable to wear a watch during work hours due to employment restrictions e.g., food service, healthcare, operating heavy machinery/construction, laboratory-based work etc.
- In addition, for patients completing interviews, the additional inclusion/exclusion criteria apply:
- Unable to provide verbal informed consent
- Unable to speak or understand English
- <18 years of age
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site
Prisma Health - Upstate
Greenville, South Carolina, 29605
Jennifer L Trilk, PhD, 864-766-2092, trilk@greenvillemed.sc.edu
Frankie Bennett, MS, 864-455-1410, bennet24@greenvillemed.sc.edu
About this study
Official title: Facilitating Health System Implementation of Physical Activity Screening and Referral to Community-Based Programs: Exercise is Medicine Greenville
A public health priority exists for the U.S. healthcare sector to integrate physical activity (PA) as a part of the patient care model. This research will provide valuable information on facilitating optimal implementation of a clinic-to-community model that identifies, refers, and enrolls physically inactive patients to community-based PA programs for the prevention and treatment of chronic diseases. Further, this work will provide evidence on the cost-effectiveness of integrating PA in healthcare systems as a population health management strategy.
Read the detailed description
There is great potential for promoting physical activity (PA) for chronic disease prevention and treatment through the health care sector. Research has demonstrated effectiveness in assessing patient PA levels, providing 'exercise prescriptions', and referring patients to evidence-based PA programs in community settings. However, implementation barriers exist, ranging from practice integration to information flow, resulting in no major health systems integrating PA as part of a comprehensive approach to patient care. In 2016, a multi-organizational partnership between a large academic healthcare system, an academic institution, and a national PA organization launched Exercise is Medicine Greenville (EIMG), a comprehensive clinic-to-community approach that involves PA assessment, prescription, and referral of patients with chronic diseases to a tailored, community-based PA program. Since 2016, EIMG has expanded to 35 Prisma Health primary care clinics and 7 community PA facilities covering >400 square miles. Despite referring >1900 patients to date, great variability exists across participating clinics in correctly identifying eligible patients and providing EIMG referrals, reducing the overall reach and efficiency of engaging patients in the community-based PA programs. Using a pragmatic, stepped wedge, cluster randomized design, this research will examine the impact of implementation facilitation (IF) on improving the implementation and reach of EIMG with patients visiting participating Prisma Health primary care clinics. At six-month intervals, 35 randomly selected clinics (6 clinics in wave 1, 8 clinics in wave 2, 10 clinics in wave 3, and 11 clinics in wave 4) will receive IF planning (3 months), active IF (6 months), and post-IF maintenance (min 12 months). The specific aims of this project are to: 1) determine differences in the level of implementation (i.e., delivery fidelity) and reach (i.e., number, proportion, representativeness of patients) at Prisma primary care health clinics before and after IF, 2) assess levels of patient engagement in and the effectiveness of the 12-week, community-based PA programs, and 3) evaluate the costs of IF and the effects of increased EIMG referrals to the community-based PA program on patients costs and clinical outcomes. The mixed methods evaluation approach is guided by the RE-AIM framework to inform the assessment of implementation outcomes, and the i-PARIHS framework to describe contextual factors (i.e., determinants) influencing patient and clinic level outcomes. Through this work, the research will identify successful IF strategies across heterogeneous health settings, helping to identify and address potential disparities in the types of patients that receive EIMG referrals, are engaged in the EIMG referral pathway, and enroll and complete the community-based PA program. Study findings will provide important information on improving future implementation and scalability of PA integration in large health systems, optimizing clinic-community linkages, and the cost savings related to primary and secondary prevention of cardiovascular disease-related health outcomes in the general patient population.
- Conditions
- Physical Inactivity, Dyslipidemia, Obesity and Overweight, Hypertension, Diabetes, Health Care Delivery
- Being tested
- Clinic Implementation Facilitation
- Keywords
- Implementation Facilitation, Physical activity referral scheme, Effectiveness-implementation hybrid type 3, Pragmatic design, Stepped wedge
- Medical subject headings
- Sedentary Behavior, Dyslipidemias, Obesity, Overweight, Hypertension, Diabetes Mellitus, Chronic Disease, Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Clinic Implementation FacilitationBehavioural
This single arm intervention will be applied to 35 Prisma Health primary care clinics where the EIMG model is currently activated. At six-month intervals, six or more clinics will receive tailored implementation facilitation (IF) based on pre-implementation facilitation findings at each clinic. We will explore factors related to achieving optimal implementation and reach of EIMG. Patient referral rates and health outcomes will also be captured as a result of changes of clinical workflow due to the IF.
| Study group | Role | What they receive |
|---|---|---|
| Clinic Implementation Facilitation | Experimental | Clinics will work with the facilitation team to address barriers and improve clinic workflow to increase patient referral rates to the community PA program. Receives: Behavioral: Clinic Implementation Facilitation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Clinic-level differences in implementation of EIMG and reach of patients receiving EIMG referrals pre- and post-implementation facilitation
Reach (primary study outcome measure) will be assessed by estimating the number and proportion of eligible patient visits engaged in EIMG by providers. A patient's visit will be considered 'engaged' if they receive an EIMG referral. The proportion is estimated by dividing patient visits with an EIMG referral by all eligible patient visits. Reach will be calculated by provider and aggregated at the clinic level.
Adoption will be assessed at the provider level by determining the number, proportion, and representativeness (i.e., sex, age, specialty) of providers that utilize any EIMG component in their practice compared to peers that do not use EIMG.
Implementation will be assessed by determining the extent to which all three steps of EIMG (i.e., assessment, prescription, patient referral) are conducted with each eligible patient at the provider level, aggregated at the clinic level.
Measured: From Wave 1 start in pre-implementation facilitation activities to the end of Wave 4 post-implementation facilitation. Time frame for Wave 1 = 39 months, Wave 2 = 33 months, Wave 3 = 27 months, Wave 4 = 21 months.
Secondary outcomes (2)
Effectiveness of participating in the community-based, 12-week evidence-informed PA program on patient PA levels and health outcomes
Effectiveness is the degree to which participating in the evidence-informed PA programs improves patient PA levels and health outcomes (i.e., changes in cardiometabolic biometric values).
Patient PA levels will be evaluated using the PAVS and objective measurement (accelerometry) before starting the PA program, after completion of the PA program, and 12 weeks post-PA program.
Patient health outcomes (i.e., body weight, blood pressure, hemoglobin A1c, lipid profiles) will be extracted from the Prisma Health electronic health record (EHR) at time of referral, after completion of the PA program, and at least 12 months after the PA program.
Measured: From the time the patient is referred to the PA program to 12 months after the patient graduates from the program
Cost of implementation facilitation and to estimate the effectiveness of increased EIMG referrals to the community-based PA on patient costs
Each ambulatory visit with an EIMG eligible diagnosis will serve as the standard unit of observation. Episodes of care will be defined after each visit through the end of follow-up and cost information will be summarized across each episode of care. For each episode of care we will extract from the EHR all healthcare utilization that occurred during the episode by type and quantity. Utilization types during the episode will be designated by Healthcare Common Procedure Coding System (HCPCS), Diagnosis Related Group (DRG), and National Drug (NDC) codes. In addition, we will use the REDCap-based data file to measure implementation costs and capture activity during the 12-week PA program. To obtain standardized costs across episodes, we will apply Prisma standard resource unit prices to all healthcare utilization. For each visit episode we will calculate Episode Healthcare Costs as the price-weighted sum of all healthcare resources used by patient "i" during the episode of care.
Measured: IF costs will be measured from start of the Pre-IF phase to end of the IF phase (9 months) for each wave. For episode specific cost, measurements are taken from the index visit (day 0) within each episode through the end of the episode of care (day 240)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Jan 2026
- Study start1 May 2026 (estimated)
- Primary completion31 Jul 2029 (estimated)
- Study completion31 Jul 2030 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Physical InactivityStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- The study will utilize a pragmatic, stepped wedge, cluster randomized design to examine the impact of implementation facilitation (IF) on increasing the reach (eligible patients that receive an EIMG referral) at 35 Prisma Health primary care clinics where the EIMG model is currently activated. At six-month intervals, randomly selected clinics will receive IF. We will use a mixed methods approach to explore factors related to achieving optimal implementation and reach of EIMG. We also will explore patient enrollment, participation, and dose-response relationships associated with changes in PA levels, health outcomes, and cost savings to the health system. Throughout the study, we will identify successful IF strategies across clinic settings, helping us identify and address potential disparities in the types of patients who receive EIMG referrals, are engaged in the EIMG referral pathway, and enroll and complete the community-based PA program.
- Masking
- None (open label)
- Enrolment
- 35 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of South Carolina
- Sponsor type
- University, hospital or other
- Collaborators
- University of South Carolina School of Medicine, Greenville, University of Nebraska, University of Utah, Temple University, Prisma Health-Upstate, Durham University
- Responsible party
- Principal investigator, Jennifer Trilk, University of South Carolina
- Investigators
- Jennifer L Trilk, PhD, Principal investigator, University of South Carolina School of Medicine, Greenville
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07340580
- Sponsor's protocol ID
- 1R01HL173601-01A1
- Status last verified
- Mar 2026
- First submitted
- 9 Jan 2026
- Last updated
- 2 Apr 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 2 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Facilitating Health System Implementation of Physical Activity Screening and Referral to Community-Based Programs: Exercise is Medicine Greenville
- ClinicalTrials.gov ID
- NCT07340580
- Acronym / sponsor ID
- 1R01HL173601-01A1
- Conditions
- Physical Inactivity, Dyslipidemia, Obesity and Overweight, Hypertension, Diabetes, Health Care Delivery
- Keywords
- Implementation Facilitation, Physical activity referral scheme, Effectiveness-implementation hybrid type 3, Pragmatic design, Stepped wedge
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 35 participants (estimated)
- Lead sponsor
- University of South CarolinaUniversity, hospital or other
- Collaborators
- University of South Carolina School of Medicine, Greenville, University of Nebraska, University of Utah, Temple University, Prisma Health-Upstate, Durham University
- Study start
- 1 May 2026 (estimated)
- Primary completion
- 31 Jul 2029 (estimated)
- Study completion
- 31 Jul 2030 (estimated)
- First posted
- 14 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A public health priority exists for the U.S. healthcare sector to integrate physical activity (PA) as a part of the patient care model. This research will provide valuable information on facilitating optimal implementation of a clinic-to-community model that identifies, refers, and enrolls physically inactive patients to community-based PA programs for the prevention and treatment of chronic diseases. Further, this work will provide evidence on the cost-effectiveness of integrating PA in healthcare systems as a population health management strategy.
Detailed description
There is great potential for promoting physical activity (PA) for chronic disease prevention and treatment through the health care sector. Research has demonstrated effectiveness in assessing patient PA levels, providing 'exercise prescriptions', and referring patients to evidence-based PA programs in community settings. However, implementation barriers exist, ranging from practice integration to information flow, resulting in no major health systems integrating PA as part of a comprehensive approach to patient care. In 2016, a multi-organizational partnership between a large academic healthcare system, an academic institution, and a national PA organization launched Exercise is Medicine Greenville (EIMG), a comprehensive clinic-to-community approach that involves PA assessment, prescription, and referral of patients with chronic diseases to a tailored, community-based PA program. Since 2016, EIMG has expanded to 35 Prisma Health primary care clinics and 7 community PA facilities covering >400 square miles. Despite referring >1900 patients to date, great variability exists across participating clinics in correctly identifying eligible patients and providing EIMG referrals, reducing the overall reach and efficiency of engaging patients in the community-based PA programs. Using a pragmatic, stepped wedge, cluster randomized design, this research will examine the impact of implementation facilitation (IF) on improving the implementation and reach of EIMG with patients visiting participating Prisma Health primary care clinics. At six-month intervals, 35 randomly selected clinics (6 clinics in wave 1, 8 clinics in wave 2, 10 clinics in wave 3, and 11 clinics in wave 4) will receive IF planning (3 months), active IF (6 months), and post-IF maintenance (min 12 months). The specific aims of this project are to: 1) determine differences in the level of implementation (i.e., delivery fidelity) and reach (i.e., number, proportion, representativeness of patients) at Prisma primary care health clinics before and after IF, 2) assess levels of patient engagement in and the effectiveness of the 12-week, community-based PA programs, and 3) evaluate the costs of IF and the effects of increased EIMG referrals to the community-based PA program on patients costs and clinical outcomes. The mixed methods evaluation approach is guided by the RE-AIM framework to inform the assessment of implementation outcomes, and the i-PARIHS framework to describe contextual factors (i.e., determinants) influencing patient and clinic level outcomes. Through this work, the research will identify successful IF strategies across heterogeneous health settings, helping to identify and address potential disparities in the types of patients that receive EIMG referrals, are engaged in the EIMG referral pathway, and enroll and complete the community-based PA program. Study findings will provide important information on improving future implementation and scalability of PA integration in large health systems, optimizing clinic-community linkages, and the cost savings related to primary and secondary prevention of cardiovascular disease-related health outcomes in the general patient population.
Study design
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- The study will utilize a pragmatic, stepped wedge, cluster randomized design to examine the impact of implementation facilitation (IF) on increasing the reach (eligible patients that receive an EIMG referral) at 35 Prisma Health primary care clinics where the EIMG model is currently activated. At six-month intervals, randomly selected clinics will receive IF. We will use a mixed methods approach to explore factors related to achieving optimal implementation and reach of EIMG. We also will explore patient enrollment, participation, and dose-response relationships associated with changes in PA levels, health outcomes, and cost savings to the health system. Throughout the study, we will identify successful IF strategies across clinic settings, helping us identify and address potential disparities in the types of patients who receive EIMG referrals, are engaged in the EIMG referral pathway, and enroll and complete the community-based PA program.
| Arm | Type | Receives |
|---|---|---|
| Clinic Implementation Facilitation | Experimental | Behavioral: Clinic Implementation FacilitationClinics will work with the facilitation team to address barriers and improve clinic workflow to increase patient referral rates to the community PA program. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (3 listed)
- Received an EIMG referral and scheduled for orientation
- Attending orientation at two pre-determined community PA facilities (these sites were selected due to each being the largest urban and rural YMCA referral sites in the study)
- Received an EIMG referral
Key exclusion criteria (73 listed)
- Not EIMG-activated
- Adopted EIMG < 6 months prior to the beginning of this study
- Greater than 15 miles from the nearest YMCA
- 1. Primary care clinic staff (primary aim) Inclusion criteria
- At least 18 years of age
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Clinic Implementation FacilitationThis single arm intervention will be applied to 35 Prisma Health primary care clinics where the EIMG model is currently activated. At six-month intervals, six or more clinics will receive tailored implementation facilitation (IF) based on pre-implementation facilitation findings at each clinic. We will explore factors related to achieving optimal implementation and reach of EIMG. Patient referral rates and health outcomes will also be captured as a result of changes of clinical workflow due to the IF. | Behavioural | Clinic Implementation Facilitation |
Primary outcome
Clinic-level differences in implementation of EIMG and reach of patients receiving EIMG referrals pre- and post-implementation facilitation
Time frame: From Wave 1 start in pre-implementation facilitation activities to the end of Wave 4 post-implementation facilitation. Time frame for Wave 1 = 39 months, Wave 2 = 33 months, Wave 3 = 27 months, Wave 4 = 21 months.
Reach (primary study outcome measure) will be assessed by estimating the number and proportion of eligible patient visits engaged in EIMG by providers. A patient's visit will be considered 'engaged' if they receive an EIMG referral. The proportion is estimated by dividing patient visits with an EIMG referral by all eligible patient visits. Reach will be calculated by provider and aggregated at the clinic level. Adoption will be assessed at the provider level by determining the number, proportion, and representativeness (i.e., sex, age, specialty) of providers that utilize any EIMG component in their practice compared to peers that do not use EIMG. Implementation will be assessed by determining the extent to which all three steps of EIMG (i.e., assessment, prescription, patient referral) are conducted with each eligible patient at the provider level, aggregated at the clinic level.
2 secondary outcomes
Effectiveness of participating in the community-based, 12-week evidence-informed PA program on patient PA levels and health outcomes
Time frame: From the time the patient is referred to the PA program to 12 months after the patient graduates from the program
Cost of implementation facilitation and to estimate the effectiveness of increased EIMG referrals to the community-based PA on patient costs
Time frame: IF costs will be measured from start of the Pre-IF phase to end of the IF phase (9 months) for each wave. For episode specific cost, measurements are taken from the index visit (day 0) within each episode through the end of the episode of care (day 240)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Apr 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Physical Inactivity
Active, not recruiting
Promoting Physical Activity in Older Hispanic/Latino(a) Adults
Sedentary Behavior, Physical Inactivity
Not yet recruiting
Individual Variability in Energy Compensation After a 12-Week Supervised Exercise Intervention
Physical Inactivity, Overweight
Not yet recruiting
Effects of Different Amounts of Plyometric Exercise Without Jumping in Physically Inactive Older Adults
Sedentary Behavior / Physical Inactivity, Aging
Active, not recruiting
E-Bike Commuting and Health in Overweight College Students
Obesity &Amp; Overweight, Sedentary Behaviors
Enrolling by invitation
Effects of a School-Based Physical Activity Intervention on 24-Hour Movement Behaviours and Motor Development in Preschool Children - Study Protocol
Physical Inactivity, Sedentariness
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Jennifer L Trilk, PhD principal investigator
University of South Carolina School of Medicine, Greenville
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Clinic Implementation Facilitation in people with Physical Inactivity and Dyslipidemia, run by University of South Carolina at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 73 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 2 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Jennifer L Trilk, PhD (864-766-2092, trilk@greenvillemed.sc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Clinic-level differences in implementation of EIMG and reach of patients receiving EIMG referrals pre- and post-implementation facilitation (time frame: From Wave 1 start in pre-implementation facilitation activities to the end of Wave 4 post-implementation facilitation. Time frame for Wave 1 = 39 months, Wave 2 = 33 months, Wave 3 = 27 months, Wave 4 = 21 months.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Apr 2026.